News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
733,001 Results
Type
Article (43703)
Company Profile (302)
Press Release (688985)
Multimedia
Podcasts (89)
Webinars (17)
Section
Business (206546)
Career Advice (2127)
Deals (36977)
Drug Delivery (115)
Drug Development (82024)
Employer Resources (174)
FDA (16604)
Job Trends (15168)
News (350850)
Policy (33339)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2639)
Accelerated approval (34)
Adcomms (25)
Allergies (146)
Alliances (50262)
ALS (171)
Alzheimer's disease (1688)
Antibody-drug conjugate (ADC) (324)
Approvals (16866)
Artificial intelligence (568)
Autoimmune disease (164)
Automation (42)
Bankruptcy (371)
Best Places to Work (11739)
BIOSECURE Act (20)
Biosimilars (195)
Biotechnology (199)
Bladder cancer (162)
Brain cancer (61)
Breast cancer (651)
Cancer (4919)
Cardiovascular disease (418)
Career advice (1798)
Career pathing (38)
CAR-T (289)
CDC (49)
Celiac Disease (2)
Cell therapy (772)
Cervical cancer (36)
Clinical research (70071)
Collaboration (1758)
Company closure (4)
Compensation (1173)
Complete response letters (61)
COVID-19 (2753)
CRISPR (96)
C-suite (870)
Cystic fibrosis (146)
Data (6324)
Decentralized trials (2)
Denatured (25)
Depression (141)
Diabetes (510)
Diagnostics (6776)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (282)
Drug pricing (189)
Drug shortages (29)
Duchenne muscular dystrophy (235)
Earnings (90525)
Editorial (59)
Employer branding (21)
Employer resources (154)
Events (118091)
Executive appointments (988)
FDA (19786)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1504)
Gene editing (204)
Generative AI (51)
Gene therapy (617)
GLP-1 (1002)
Government (4749)
Grass and pollen (6)
Guidances (384)
Healthcare (19114)
HIV (64)
Huntington's disease (45)
IgA nephropathy (86)
Immunology and inflammation (262)
Immuno-oncology (62)
Indications (118)
Infectious disease (3033)
Inflammatory bowel disease (199)
Inflation Reduction Act (14)
Influenza (121)
Intellectual property (256)
Interviews (340)
IPO (16742)
IRA (51)
Job creations (3767)
Job search strategy (1497)
JPM (60)
Kidney cancer (16)
Labor market (86)
Layoffs (574)
Leadership (34)
Legal (8158)
Liver cancer (91)
Longevity (15)
Lung cancer (667)
Lymphoma (384)
Machine learning (42)
Management (61)
Manufacturing (830)
MASH (167)
Medical device (13959)
Medtech (14016)
Mergers & acquisitions (21332)
Metabolic disorders (1301)
Multiple sclerosis (166)
NASH (16)
Neurodegenerative disease (327)
Neuropsychiatric disorders (95)
Neuroscience (2962)
Neurotech (1)
NextGen: Class of 2026 (6670)
Non-profit (4570)
Now hiring (68)
Obesity (615)
Opinion (281)
Ovarian cancer (168)
Pain (199)
Pancreatic cancer (232)
Parkinson's disease (287)
Partnered (33)
Patents (512)
Patient recruitment (501)
Peanut (58)
People (59482)
Pharmaceutical (70)
Pharmacy benefit managers (30)
Phase 1 (21850)
Phase 2 (30806)
Phase 3 (22993)
Pipeline (5471)
Policy (291)
Postmarket research (2597)
Preclinical (9287)
Press Release (66)
Prostate cancer (243)
Psychedelics (49)
Radiopharmaceuticals (290)
Rare diseases (868)
Real estate (6055)
Recruiting (70)
Regulatory (24937)
Reports (54)
Research institute (2446)
Resumes & cover letters (365)
Rett syndrome (27)
RNA editing (17)
RSV (82)
Schizophrenia (153)
Series A (249)
Series B (195)
Service/supplier (12)
Sickle cell disease (98)
Special edition (24)
Spinal muscular atrophy (159)
Sponsored (42)
Startups (3717)
State (2)
Stomach cancer (18)
Supply chain (107)
Tariffs (85)
The Weekly (62)
Vaccines (1033)
Venture capital (91)
Weight loss (398)
Women's health (93)
Worklife (18)
Date
Last 7 days (571)
Last 30 days (2284)
Last 365 days (30349)
2026 (4043)
2025 (30927)
2024 (35717)
2023 (40313)
2022 (51451)
2021 (56042)
2020 (54506)
2019 (47133)
2018 (35550)
2017 (32632)
2016 (32074)
2015 (38100)
2014 (31835)
2013 (26893)
2012 (29087)
2011 (29779)
2010 (27885)
Location
Africa (774)
Alabama (84)
Alaska (7)
Arizona (313)
Arkansas (13)
Asia (40303)
Australia (6581)
California (11446)
Canada (3329)
China (1124)
Colorado (481)
Connecticut (486)
Delaware (341)
Europe (87169)
Florida (1716)
Georgia (363)
Hawaii (3)
Idaho (64)
Illinois (879)
India (69)
Indiana (531)
Iowa (22)
Japan (438)
Kansas (128)
Kentucky (41)
Louisiana (27)
Maine (72)
Maryland (1403)
Massachusetts (8233)
Michigan (331)
Minnesota (632)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (124)
New Hampshire (82)
New Jersey (3035)
New Mexico (29)
New York (3028)
North Carolina (1474)
North Dakota (8)
Northern California (5593)
Ohio (342)
Oklahoma (21)
Oregon (42)
Pennsylvania (2310)
Puerto Rico (24)
Rhode Island (48)
South America (1151)
South Carolina (67)
South Dakota (1)
Southern California (4453)
Tennessee (179)
Texas (1764)
United States (40638)
Utah (346)
Vermont (1)
Virginia (266)
Washington D.C. (83)
Washington State (932)
West Virginia (4)
Wisconsin (112)
Wyoming (2)
733,001 Results for "sequitur inc acquired by invitrogen".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioSyent to Acquire Oral Science Inc.
February 9, 2026
·
10 min read
Press Releases
Lightship Inc. Acquires Veda Trials to Expand Community-Based Clinical Research Delivery
February 5, 2026
·
3 min read
Press Releases
Boston Scientific announces agreement to acquire Penumbra, Inc.
January 16, 2026
·
15 min read
Press Releases
Lightship Inc. Acquires Veda Trials to Expand Community-Based Clinical Research Delivery
The acquisition expands scalable trial operations across real-world care settings
February 4, 2026
·
1 min read
Press Releases
ABS Bio, Inc. acquires Cureline, Inc. to strengthen support of biopharma drug discovery
January 7, 2026
·
1 min read
Press Releases
Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.
November 17, 2025
·
17 min read
Press Releases
Novo Nordisk will not increase its proposal to acquire Metsera, Inc.
November 10, 2025
·
2 min read
Press Releases
Novo Nordisk submits proposal to acquire Metsera, Inc.
October 30, 2025
·
2 min read
Press Releases
Novo Nordisk submits updated proposal to acquire Metsera, Inc.
November 5, 2025
·
3 min read
Press Releases
Sun Pharma Canada Inc. Acquires Commercial Rights to LEVULAN® KERASTICK®
November 13, 2025
·
4 min read
1 of 73,301
Next
